ArticleScience advances2021

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin.

Pike-See Cheah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.